These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17341557)

  • 1. Formation of ethinyl estradiol in women during treatment with norethindrone acetate.
    Chu MC; Zhang X; Gentzschein E; Stanczyk FZ; Lobo RA
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2205-7. PubMed ID: 17341557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
    Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
    Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.
    Kuhnz W; Heuner A; Hümpel M; Seifert W; Michaelis K
    Contraception; 1997 Dec; 56(6):379-85. PubMed ID: 9494772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norethisterone and ethinyl estradiol kinetics during dapsone therapy.
    Joshi JV; Maitra A; Sankolli G; Bhatki S; Joshi UM
    J Assoc Physicians India; 1984 Feb; 32(2):191-3. PubMed ID: 6746515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR; Colburn W; Kook KA; Thomas SD
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women.
    Sekar VJ; Lefebvre E; Guzman SS; Felicione E; De Pauw M; Vangeneugden T; Hoetelmans RM
    Antivir Ther; 2008; 13(4):563-9. PubMed ID: 18672535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of sumatriptan when administered with norethindrone 1 mg/ethinyl estradiol 0.035 mg in healthy volunteers.
    Moore KH; McNeal S; Britto MR; Bye C; Sale M; Richardson MS
    Clin Ther; 2002 Nov; 24(11):1887-901. PubMed ID: 12501881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.
    Fels H; Steward R; Melamed A; Granat A; Stanczyk FZ; Mishell DR
    Contraception; 2013 Jun; 87(6):732-7. PubMed ID: 23352800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms.
    Speroff L; Symons J; Kempfert N; Rowan J;
    Menopause; 2000; 7(6):383-90. PubMed ID: 11127760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy women.
    Kasserra C; Li J; March B; O'Mara E
    Clin Ther; 2011 Oct; 33(10):1503-14. PubMed ID: 22015327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women.
    Mildvan D; Yarrish R; Marshak A; Hutman HW; McDonough M; Lamson M; Robinson P
    J Acquir Immune Defic Syndr; 2002 Apr; 29(5):471-7. PubMed ID: 11981363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women.
    Back DJ; Breckenridge AM; Crawford FE; Hall JM; MacIver M; Orme ML; Rowe PH; Smith E; Watts MJ
    Contraception; 1980 Feb; 21(2):135-43. PubMed ID: 7189454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate.
    Klehr-Bathmann I; Kuhl H
    Maturitas; 1995 Apr; 21(3):245-50. PubMed ID: 7616874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of three bioequivalent norethindrone/mestranol-50 micrograms and three norethindrone/ethinyl estradiol-35 micrograms OC formulations: are "low-dose" pills really lower?
    Brody SA; Turkes A; Goldzieher JW
    Contraception; 1989 Sep; 40(3):269-84. PubMed ID: 2766722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Hampton RM; Zhang HF; Barnowski C; Wan GJ
    Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe).
    Nakajima ST; Archer DF; Ellman H
    Contraception; 2007 Jan; 75(1):16-22. PubMed ID: 17161118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, does not affect the pharmacokinetics of ethinyl estradiol or norethindrone in healthy female subjects.
    Migoya E; Larson P; Bergman A; Miller J; Johnson-Levonas AO; Lasseter KC; Wagner JA
    J Clin Pharmacol; 2011 Sep; 51(9):1319-25. PubMed ID: 21209231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding.
    Murphy PA; Kern SE; Stanczyk FZ; Westhoff CL
    Contraception; 2005 Jun; 71(6):402-8. PubMed ID: 15914127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.